PG · NYQ · Consumer Defensive
The Procter & Gamble Company
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 104.95
Market price
USD 146.39
Implied upside
-28.3%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 88.8bn | USD 90.6bn | USD 92.4bn | USD 94.2bn | USD 96.1bn | +2.0% |
| EBIT | USD 20.6bn | USD 21.0bn | USD 21.4bn | USD 21.8bn | USD 22.3bn | +2.0% |
| NOPAT | USD 16.4bn | USD 16.7bn | USD 17.1bn | USD 17.4bn | USD 17.8bn | +2.0% |
| Add depreciation & amortisation | USD 3.1bn | USD 3.1bn | USD 3.2bn | USD 3.2bn | USD 3.3bn | +2.0% |
| Less capital expenditure | USD -3.8bn | USD -3.9bn | USD -4.0bn | USD -4.1bn | USD -4.1bn | +2.0% |
| Less increase in working capital | USD 36.0m | USD 36.7m | USD 37.5m | USD 38.2m | USD 39.0m | -2.0% |
| Free cashflow to firm | USD 15.7bn | USD 16.0bn | USD 16.3bn | USD 16.6bn | USD 17.0bn | +2.0% |
| Discount factor | 0.9631 | 0.8933 | 0.8286 | 0.7686 | 0.7130 | - |
| Present value | USD 15.1bn | USD 14.3bn | USD 13.5bn | USD 12.8bn | USD 12.1bn | -5.4% |
| Present Value Of The Forecast | USD 67.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.583 | Reported 0.377, pulled toward 1.0 (Blume) |
| Cost of equity | 8.20% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.00% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | USD 340.0bn | 90.7% of capital |
| Total debt | USD 35.0bn | 9.3% of capital, book value as a proxy |
| Tax rate | 20.3% | Effective, capped at statutory |
| WACC | 7.81% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
76% of EV
- Forecast FCFF, final year
- USD 17.0bn
- Capex at depreciation, working capital in reinvestment
- USD 17.8bn
- Less reinvestment at g/ROIC (13.5% of NOPAT)
- USD -2.4bn
- Capitalised
- USD 15.4bn
- ROIC (reported)
- 18.5%
- Terminal value, undiscounted
- USD 296.7bn
- Terminal value, discounted
- USD 211.5bn
- Enterprise value
- USD 279.3bn
- Less net debt
- USD 25.1bn
- Equity value
- USD 254.2bn
Exit at 15.9x EBITDA
81% of EV
- Terminal value, undiscounted
- USD 407.8bn
- Terminal value, discounted
- USD 290.7bn
- Enterprise value
- USD 358.5bn
- Less net debt
- USD 25.1bn
- Equity value
- USD 333.4bn
Spread between methods: 27%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.81% | 142.06 | 154.80 | 171.34 | 193.72 | 225.73 |
| 6.81% | 114.06 | 121.42 | 130.45 | 141.82 | 156.58 |
| 7.81% | 94.93 | 99.52 | 104.95 | 111.47 | 119.48 |
| 8.81% | 81.03 | 84.04 | 87.51 | 91.55 | 96.32 |
| 9.81% | 70.47 | 72.52 | 74.82 | 77.45 | 80.47 |
Outlined: this model. Green text: above today's price of 146.39. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 2.0% | 9.1% | +7.1pp |
| EBIT margin | 23.2% | 31.4% | +8.2pp |
| Discount rate | 7.8% | 6.4% | -1.5pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.